Walleye Capital
APGN

Walleye Capital’s Apexigen, Inc. Common Stock APGN Stock Holding History

Walleye Capital’s Portfolio APGN Stock Details APGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-16,400
Closed -$11.3K – 4534
2022
Q4 		$11.3K Hold
16,400
– – ﹤0.01% 2743
2022
Q3 		$44K Buy
+16,400
New +$133K ﹤0.01% 2613

Other funds holding APGN

DCMIC
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Walleye Capital's APGN Position: Q3 2022 in Review

Walleye Capital sold out of Apexigen, Inc. Common Stock (APGN) in Q3 2022, closing a stake of 42,934 shares — an estimated $349K sold.

Walleye Capital first reported a position in APGN in Q4 2021 and held it in 2 quarters. The position peaked at $436K in Q2 2022. 18 funds tracked by Wall St. Rank hold APGN as of Q3 2022.

  • Walleye Capital reported no remaining Apexigen, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Walleye Capital sold 42,934 Apexigen, Inc. Common Stock shares in Q3 2022, an estimated $349K.
  • Walleye Capital first reported a position in Apexigen, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
  • Walleye Capital's Apexigen, Inc. Common Stock position peaked at $436K in Q2 2022.
  • 18 funds tracked by Wall St. Rank held Apexigen, Inc. Common Stock as of Q3 2022.

Based on Walleye Capital's 13F filing for Q3 2022, filed 14 Nov 2022.